3.87
전일 마감가:
$3.85
열려 있는:
$3.885
하루 거래량:
875.98K
Relative Volume:
0.89
시가총액:
$220.49M
수익:
-
순이익/손실:
$-82.44M
주가수익비율:
-2.0585
EPS:
-1.88
순현금흐름:
$-66.75M
1주 성능:
-2.52%
1개월 성능:
-1.53%
6개월 성능:
+92.54%
1년 성능:
+54.18%
Black Diamond Therapeutics Inc Stock (BDTX) Company Profile
명칭
Black Diamond Therapeutics Inc
전화
617-417-5868
주소
ONE MAIN STREET, 14TH FLOOR, CAMBRIDGE, MA
BDTX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
BDTX
Black Diamond Therapeutics Inc
|
3.87 | 219.35M | 0 | -82.44M | -66.75M | -1.88 |
|
VRTX
Vertex Pharmaceuticals Inc
|
429.82 | 107.58B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
787.32 | 80.03B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.80 | 57.37B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
917.93 | 55.83B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
209.02 | 44.13B | 447.02M | -1.18B | -906.14M | -6.1812 |
Black Diamond Therapeutics Inc Stock (BDTX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-11-18 | 재개 | Piper Sandler | Overweight |
| 2025-10-16 | 재개 | Stifel | Buy |
| 2025-09-04 | 개시 | Guggenheim | Buy |
| 2025-07-01 | 재개 | Raymond James | Outperform |
| 2024-07-31 | 개시 | Raymond James | Outperform |
| 2023-07-14 | 개시 | Piper Sandler | Overweight |
| 2023-06-30 | 업그레이드 | Stifel | Hold → Buy |
| 2023-06-28 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2023-06-27 | 업그레이드 | Wedbush | Neutral → Outperform |
| 2022-03-29 | 다운그레이드 | Wedbush | Outperform → Neutral |
| 2022-03-22 | 다운그레이드 | H.C. Wainwright | Buy → Neutral |
| 2021-09-30 | 개시 | Stifel | Hold |
| 2021-01-07 | 개시 | Wedbush | Outperform |
| 2020-11-24 | 개시 | Berenberg | Buy |
| 2020-05-04 | 개시 | H.C. Wainwright | Buy |
| 2020-02-24 | 개시 | Canaccord Genuity | Buy |
| 2020-02-24 | 개시 | Cowen | Outperform |
| 2020-02-24 | 개시 | JP Morgan | Overweight |
| 2020-02-24 | 개시 | Jefferies | Buy |
모두보기
Black Diamond Therapeutics Inc 주식(BDTX)의 최신 뉴스
Black Diamond Therapeutics Inc. (BDTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What insider trading reveals about Black Diamond Therapeutics Inc. stockQuarterly Profit Review & Fast Exit and Entry Strategy Plans - newser.com
Black Diamond Therapeutics: Underappreciated Despite An Upcoming Key Readout (NASDAQ:BDTX) - Seeking Alpha
Will Black Diamond Therapeutics Inc. stock pay special dividends2025 Momentum Check & Reliable Intraday Trade Plans - newser.com
Black Diamond Therapeutics (NASDAQ:BDTX) Upgraded at Piper Sandler - Defense World
Can Black Diamond Therapeutics Inc. stock hit record highs againJuly 2025 Review & Comprehensive Market Scan Reports - newser.com
Will Black Diamond Therapeutics Inc. stock maintain momentum in 2025July 2025 Highlights & AI Based Buy/Sell Signal Reports - newser.com
Volume spikes in Black Diamond Therapeutics Inc. stock – what they meanQuarterly Growth Report & Expert Curated Trade Setups - newser.com
How geopolitical tensions affect Black Diamond Therapeutics Inc. stockJuly 2025 Short Interest & AI Powered Market Entry Strategies - newser.com
It makes sense and dollars to buy Black Diamond Therapeutics Inc (BDTX) stock - Setenews
How to read the order book for Black Diamond Therapeutics Inc.Earnings Recap Summary & Expert Verified Stock Movement Alerts - newser.com
Piper Sandler Assumes Coverage on BDTX with Overweight Rating | - GuruFocus
Tools to assess Black Diamond Therapeutics Inc.’s risk profileMarket Rally & Weekly Market Pulse Updates - newser.com
Can Black Diamond Therapeutics Inc. stock outperform in 2025 bull marketQuarterly Earnings Summary & Long-Term Capital Growth Ideas - newser.com
15,800 Shares in Black Diamond Therapeutics, Inc. $BDTX Bought by Bailard Inc. - Defense World
Is Black Diamond Therapeutics Inc. trending in predictive chart models2025 Breakouts & Breakdowns & Safe Capital Allocation Plans - newser.com
Real time scanner hits for Black Diamond Therapeutics Inc. explained2025 Top Gainers & Verified Short-Term Trading Plans - newser.com
What is HC Wainwright’s Estimate for BDTX FY2025 Earnings? - Defense World
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Applied Therapeutics (APLT) and Xilio Therapeutics (XLO) - The Globe and Mail
Black Diamond Therapeutics files for mixed shelf of up to $500 millionSEC filing - MarketScreener
Black Diamond Therapeutics, Inc. (BDTX) Hits Fresh High: Is There Still Room to Run? - sharewise.com
Black Diamond Therapeutics Inc (BDTX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):